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InﬂammationWe have recently shown that resistin is a key mediator of arthritis accumulating in the inﬂamed joints and
exerting its pro-inﬂammatory properties independently of TNFα. Here we evaluate neutrophils as a cellular
source of resistin. Human neutrophils were subjected to subcellular fractionation where the presence of
resistin was assessed using western blot, ELISA, and mass spectrometry. Presence of resistin on the
neutrophil surface was visualized by ﬂow cytometry. More than 95% of the neutrophils in circulation and in
synovial ﬂuid express resistin on their surface. Stimulation of mature neutrophils with fMLF induced release
of resistin into supernatants and increased expression of resistin on the surface. Resistin is mobilized
simultaneously with lactoferrin, a protein found in speciﬁc granules, and with granule-stored CR3/CD11b.
Subcellular fractionation of human neutrophils demonstrated the presence of resistin in azurophilic and in
speciﬁc granules. Here we show that neutrophils have two pools of resistin, the major one exists in speciﬁc
granules, and the second on their cell membrane. Release of resistin from the neutrophil granules probably
serves the main source of resistin at the site of inﬂammation.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
Resistin was originally described in mice as an adipocyte-derived
polypeptide regulating adipocyte differentiation and modulating
insulin-signaling pathway, hence leading to insulin resistance [1].
Resistin is a cysteine-rich protein belonging to the family of proteins
found in inﬂammatory zone (FIZZ). Mouse resistin is secreted from
adipocytes as a dimer, [2] though the functional relevance of dime-
rization has yet to be determined. Recent studies suggest that resistin
can form multimeric complexes consisting of resistin homomers or
heteromers with other proteins of resistin-like family [3]. Human
resistin exhibits only a partial homology to its murine counterpart
(59% amino acid identity) and displays a signiﬁcant diversity in
functions and tissue distribution [4]. Human resistin is highly
expressed in mononuclear blood cells, in spleen, bone marrow, lung
tissue, endothelial cells, and placenta being scantily expressed in fat
tissues of lean subjects [5]. We have recently reported that human
resistin is an important regulator of inﬂammatory cytokine cascade
mediating its pro-inﬂammatory effects through NF-κB signaling
pathway and functioning independently of TNFα [6]. Resistin is
readily upregulated and released by mononuclear leukocytes follow-
ing pro-inﬂammatory stimuli such as TNFα, peptidoglycans, and
endotoxin [6]. Increased circulating levels of resistin in man are
frequently found in association with inﬂammation. Indeed, resistin isBokarewa).
ll rights reserved.accumulated at the site of inﬂammation, e.g. in joints and salivary
glands [7–9] and correlates to other acute phase reactants as C-
reactive protein, IL-6, and local leukocyte counts.
Neutrophils are phagocytic cells representing the major fraction of
leukocytes in circulation. Efﬁcient extravasation of neutrophils from
blood into inﬂamed tissues, followed by a release of their granular
content is one of major mechanisms of the innate immune responses.
Activation of neutrophils occurs by chemoattractant mediators,
among which small formyl peptide derivates (fMLF) of prokaryotic
or mitochondrial origin are the best characterized [10,11]. The fMLF
binding to its receptor (FPR) triggers intracellular activation mediated
by guanine nucleotide regulatory proteins (G-proteins) resulting in
phosphorylation of intracellular kinases, including phosphatidylino-
sitol-3-kinase, protein kinase C, mitogen-activated protein kinases,
and release of granular content [11,12]. The granular proteins of
neutrophils are key players in immune reactions responsible for the
direct elimination of microbial intruders, and being effector molecules
in tissue remodeling during inﬂammation [12–15]. Human neutro-
phils express at least four subsets of granules/vesicles: primary or
azurophil granules, secondary or speciﬁc granules, gelatinase gran-
ules, and secretory vesicles [14]. The precise content of each
individual granule type is not fully characterized yet. However, the
importance of already known vesicular proteins regarding both
bacterial killing and host tissue damage has been demonstrated
both in vivo and in vitro.
In this study, we identiﬁed human neutrophils as an important
source of resistin. Subcellular fractionation of neutrophils identiﬁed
the presence of resistin in azurophil and in speciﬁc granules as well as
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through FPR but not through TNFα receptor, induces extracellular
release of resistin accompanied by the release of lactoferrin, a marker
of speciﬁc granules. Our ﬁndings support the critical role of resistin at
the initial stages of inﬂammatory process.
2. Material and methods
2.1. Chemicals and reagents
Dextran and Ficoll-Paque were purchased from Amersham
Pharmacia Biotec AB (Uppsala, Sweden) N-formyl-Met-Leu-Phe
(fMLF), was purchased from (Sigma-Aldrich, Steinheim, Germany).
Percoll and Ficoll-Paque were purchased from Pharmacia, Uppsala,
Sweden. The diisopropyl ﬂuorophosphates (DFP) was obtained from
Aldrich, Steinhem, Germany. The [57Co]vitamin B12 was supplied by
ICN, Costa Mesa, CA. Alkaline phosphatase conjugated streptavidin
and 1,2-phenylenediamine (OPD) were purchased from Dako,
Glostrup, Denmark. The pefabloc and bovine serum albumin (BSA)
were obtained from Boehringer Mannheim, Mannheim, Germany.
Polyvinylidene diﬂuoride (PVDF) membranes were from Millipore,
Bedford, MA. The rabbit anti-gelatinase antibody was purchased from
Chemicon (Temecula, CA). Recombinant TNFαwas from R&D systems
(Abingdon, Oxon, UK) and recombinant resistin was from Peprotech
(PeproTech, UK; endotoxin concentration b0.1 ng/μg) diluted in PBS
containing 1% of BSA. Monoclonal mouse anti-human resistin anti-
bodies (clone 184320, used for ﬂow cytometry, and clone 184335,
usedWestern blot and as capture antibodies in ELISA), and polyclonal
goat anti-human resistin antibodies were purchased from R&D
Systems. Afﬁnity puriﬁed polyclonal rabbit anti-human resistin antib-
odies (Lot. 025 k4806, used for immunohistology) were purchased
from Sigma. Biotinylatedmouse IgG2B isotype control (BDDiagnostics,
Franklin Lakes, NJ) was used for the FACS analysis.
2.2. Isolation of human neutrophils
Peripheral blood neutrophils were isolated from human buffy
coats obtained from adult healthy blood donors (The blood donor
center, Sahlgrenska University Hospital, Gothenburg). Erythrocytes
were depleted by dextran (2%) sedimentation at 1×g. Granulocytes,
in the leukocyte rich supernatant, were separated from the mononu-
clear cells by gradient centrifugation on Ficoll-Paque. The remaining
erythrocytes were eliminated by hypotonic lysis. Neutrophils were
washed and re-suspended in Krebs–Ringer phosphate buffer contain-
ing 10 mM glucose (KRG, pH 7.3; 120 mM NaCl, 5 mM KCl, 1.7 mM
KH2PO4, 8.3 mM NaHPO4, 1 mM Ca2+, 1.5 mM Mg2+ and 10 mM
glucose) and stored on ice until use.
2.3. Samples of human synovial ﬂuid and blood
Paired blood and synovial ﬂuid samples were obtained from 6
patients (4 rheumatoid arthritis, 2 spondyloarthritis, age 32–
67 years). Additionally, blood samples were obtained from 9 healthy
individuals (4 men, 5 women, age 23–42 years). Synovial ﬂuid was
obtained from knee joints by arthrocenthesis and immediately trans-
ferred into the heparin coated tubes. Blood samples were obtained
from the cubical vein directly into the heparin coated tubes. The
leukocytes were prepared from 200 μl of the sedimented cell pellets
by lysing erythrocytes with NH4Cl, washing with PBS containing 1% of
FCS and 0.5 mM EDTA. The leukocyte pellet was obtained by centri-
fugation at 200g for 5 min and to FACS analysis.
2.4. Immunohistochemistry of human synovial tissue
Human synovial tissue of excised during a joint replacement
surgery was submitted to routine ﬁxation and parafﬁn embedding,and cut into 4 μm thin sections. Tissue sections were deparafﬁnized
and incubated with rabbit anti-human resistin antibodies (Sigma).
After washing in PBS, the sections were incubated with biotinylated
secondary goat anti-rabbit IgG antibodies (5 μg/ml). Color reaction
was completed with Vectastain Elit ABC kit (VectorLaboratories Inc.,
Burlingame, CA) and 3-amino-9-ethyl-carbazole containing H2O2.
Sec>tions were counterstained with hematoxylin.
2.5. Subcellular fractionation of neutrophils
Subcellular fractionation of neutrophils isolated from buffy coats
was performed according to the method described [16]. Brieﬂy,
neutrophils were incubated with the serine protease inhibitor diiso-
propyl ﬂuorophosphate for 5 min, pelleted, resuspended in disruption
buffer and disrupted by nitrogen cavitation. The post-nuclear super-
natant was collected after centrifugation of the homogenate at 400g
for 15 min at 4 °C. Postnuclear supernatant (10 ml) was carefully
applied on top of a Percoll gradient. To separate azurophil granules,
speciﬁc granules and secretory vesicles/plasma membrane, the
postnuclear supernatant was layered on top of a two-layer Percoll
gradient with densities of 1.05 g/ml and 1.12 g/ml. After centrifuga-
tion at 37,000g for 30 min, the three distinct fractions containing
subcellular organelles appeared. Fractions of 1ml were aspirated from
the bottom of the gradient.
To generate better separation of speciﬁc granules from gelatinase
granules, a three-layer gradient with Percoll solutions of 1.05, 1.09
and 1.12 g/ml was used. The distribution of subcellular organelles in
the fractions was analyzed by marker analysis (the plasma mem-
brane/secretory vesicles marker alkaline phosphatase), the speciﬁc
granule marker vitamin B12-binding protein and azurophil granule
marker myeloperoxidase). A portion of fractions were diluted in 2x
non-reduced SDS-PAGE sample buffer and stored at −80 °C for
subsequent Western blot analysis.
2.6. SDS-PAGE and Western blot
Heat denatured samples (100 °C for 5 min) were loaded on 15%
sodium dodecyl sulfate polyacrylamide (SDS-PAGE) gel and trans-
ferred to nitrocellulose membranes (Amersham Bioscience) by
electroblotting. The membranes containing proteins were incubated
in blocking buffer (1% BSA, 1% skim milk, 0.1 % Tween-20 in PBS) for
1 h at RT followed by the addition of a monoclonal mouse anti-resistin
antibody (1:1000). The blots were incubated overnight at 4 °C and
subsequently incubated with HRP-conjugated anti-mouse IgG
(1:1000). The localization of resistin was visualized by chemilumi-
nescence. Gelatinase, a marker for speciﬁc and gelatinase granules
was detected byWestern blot using a polyclonal rabbit anti-gelatinase
antibody and a secondary peroxidase-conjugated goat anti-rabbit
immunoglobulin G (IgG) antibody.
2.7. Mass spectrometry
Pieces of SDS-PAGE gel of neutrophil fractions 3, 8, and 20 and
corresponding to resistin bands were cut out and submitted to mass
spectrometric analysis at Core Facility of the University of Göteborg. In
short, proteins were tryptic digested in-gel, extracted peptides
analyzed by nano-LC ESI mass spectrometry (LTQ-FTICR). Data were
searched against Swissprot protein database. The observed peptide
mass and fragmented spectra were matched against theoretical
peptides and combined into protein hits.
2.8. Neutrophil exocytosis
Puriﬁed human neutrophils (5×106 cells) were resuspended in
500 μl KRG. For triggering the granule mobilization and granular
protein secretion, cell suspensionwas pre-incubated for 5min at 37 °C
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were then further incubated at 37 °C for different time as indicated.
The exocytosis was stopped by transferring cells onto ice. Following
centrifugation, the cell-free supernatant containing exocytosed pro-
teins was collected. The supernatant was stored at −20 °C for a
subsequent resistin and lactoferrin measurement. The remaining cell
pellet was ﬁxed in 4% paraformaldehyde, washed and stored in FACS
buffer (PBS, 0.02% NaN3, 0.1 mM EDTA before further FACS analysis.
2.9. Resistin levels
Resistin levels in supernatants and in neutrophil fractions were
determined by a sandwich ELISA. Brieﬂy, samples diluted 1:10 in PBS
with 0.01 mg/ml Na-azide were introduced into thewells coated with
capture monoclonal mouse anti-human resistin Abs (IgG2B clone
184335, 0.4 μg/ml). Biotinylated polyclonal goat anti-human resistin
Abs (200 ng/ml) were used in the detection step of ELISA.
Myeloperoxidase and alkaline phosphatase are enzymes enriched in
neutrophil fractions due to their presence in granules. The presence of
these enzymes may inﬂuence ﬁnal step of ELISA. To diminish a
possible inﬂuence of myeloperoxidase present in neutrophil fractions
on detection of resistin, 0.01 mg/ml of Na-azide, myeloperoxidase
inhibitor, was used for sample dilution as well as in all the buffers of
ELISA. Additionally, speciﬁc resistin–anti-resistin complex formation
was visualized by two independent development systems—employ-
ing Streptavidin-HRP and Streptavidin-ALP conjugates. The obtained
absorbance values were compared with serial dilution of recombinant
human resistin. Lowest detectable level was 15 pg/ml.
2.10. Lactoferrin levels
Lactoferrin levels were measured in supernatants by a sandwich
ELISA (Hycult biotechnology, Uden, Netherlands). Supernatants were
diluted 1:5 in dilution buffer. Lactoferrin was quantiﬁed following
serial dilution of recombinant protein provided by the manufacturer.
The lowest detectable level was 0.4 ng/ml.
2.11. Flow cytometry
Leukocytes from peripheral blood and from synovial ﬂuid were
prepared as described above and incubated with 20 μl of biotin-
labelled anti-resistin antibodies (R&D Systems) or mouse IgG2b iso-
type control (Beckton Dickinson, Erembodegum, Belgium). Phenotype
of leukocyte populations was visualized using anti-CD16 (FITC-
conjugated), anti-CD3 (PerCP-conjugated), and anti-CD14 (PE-conju-
gated). At the end of incubation erythrocytes were lysed using 3 ml of
lysing buffer (Beckton Dickinson) for additional 15 min. Leukocytes
were sedimented by centrifugation at 800g for 5 min and stained with
streptavidin-APC. To visualize CR3/CD11b on the surface of neutro-
phils, cells were stimulated as indicated and resuspended in 100 μl
FACS buffer were incubated with PE-conjugated monoclonal antibody
against CR3/CD11b (1:200) for 30 min on ice. Following incubation at
the room temperature, stainingwas discontinued bywashing, and cell
pellet was re-suspended in the PBS buffer containing 1% FCS, 0.5 mM
EDTA, and 0.1% NaN3. The cells were then washed, resuspended in
FACS buffer and examined on a FACscan. We analyzed 50,000 cells
with a FACS Cantor equipped with FlowJo software.
2.12. Statistical analyses
Cell stimulation experiments were performed in triplicates and at
three independent occasions. The level of continuous variables was
expressed as mean±SEM. Difference between the groups was
calculated separately employing the Mann–Whitney U test. Correla-
tions between parameters studied were calculated employingSpearman correlation coefﬁcient. For all the statistical evaluation of
the results, p-values below 0.05 were considered signiﬁcant.
3. Results
3.1. Resistin is abundantly expressed on the surface of human
neutrophils
Immunological evaluation of human synovia obtained from a
patient with rheumatoid arthritis visualized the presence of resistin-
positive leukocytes in the intimal lining layer (Fig. 1A). In arthritis
synovial ﬂuid is enriched with resistin as compared to circulation
[6,9]. To evaluate further the cellular source of resistin, the presence of
resistin on the surface of human leukocytes in blood and synovial ﬂuid
was studied. Paired leukocyte populations were obtained from
peripheral blood and from synovial ﬂuid of patients with arthritis
(n=6) and stained for resistin and subjected to ﬂow cytometry.
Additionally, peripheral blood leukocytes of 9 healthy individuals
were stained for surface resistin. Neutrophil, deﬁned as CD16+,
monocyte (CD14+) and T lymphocyte (CD3+) cell populations were
gated and analyzed for resistin expression. Resistin was identiﬁed on
the surface of 95-98% of non-stimulated neutrophils from synovial
ﬂuid (MFI: 93.8±2.2). Surface expression of resistin on the
neutrophils of peripheral blood was signiﬁcantly lower (Fig. 1B, C).
Resistin was also detected on the surface of monocytes (MFI: 38.5±
3.4) and lymphocytes (MFI: 26.5±11.3). We observed no difference
in surface expression of resistin in blood leukocytes of the patients
with arthritis and of healthy individuals.
3.2. Resistin is released from intracellular stores following activation of
human neutrophils
To evaluate the ability of pro-inﬂammatory stimuli to alter surface
expression of resistin, freshly isolated human neutrophils (106 cells,
n=6) were stimulated with increasing concentrations of fMLF and
TNFα, and submitted to FACS analysis. Short-time stimulation of
neutrophils (10 min) with fMLF, in concentrations 10−10 to 10−7 M,
resulted in an increase of surface resistin irrespectively of fMLF
concentrations. Similar changes in the expression of resistin on
surface of neutrophils were observed following TNFα stimulation
(Fig. 2). Release of resistin from neutrophils was evaluated following
stimulation of puriﬁed neutrophils (106 cells) with increasing
amounts of fMLF and TNFα. The supernatants were collected at the
indicated time intervals, and resistin levels were measured. Follow-
ing 10 min stimulation of neutrophils with fMLF, an almost three-fold
increase of resistin in the cell-free supernatant was observed as
compared to the non-stimulated cells (Fig. 3A). Resistin release was
dependent on fMLF concentration. In contrast, stimulation of
neutrophils with TNFα did not increase resistin levels in super-
natants as compared to non-stimulated cells (Fig. 3B). Taken
together, we show that pro-inﬂammatory stimuli as TNFα and
fMLF may induce changes in the expression of resistin on the cellular
surface. Additionally, resistin is secreted from human neutrophils
following stimulation with fMLF.
3.3. Resistin is released upon stimulation simultaneously with the
mobilization of neutrophil granules
To test whether resistin is stored in the neutrophil granules, the
release of resistin was measured in parallel with lactoferrin, a protein
of speciﬁc granules. The cell-free supernatants were collected
following fMLF stimulation showed that the level of lactoferrin
increased dose-dependently in the supernatants following stimula-
tion with fMLF (Fig. 3A). In contrast, TNFα stimulated cells did not
induce secretion of lactoferrin into the supernatants (Fig. 3B). This
release pattern correlates well with the pattern of resistin release
Fig. 1. Expression of resistin in synovial tissue, synovial leukocytes and peripheral blood of patients with rheumatoid arthritis. (A) Immunohistology of human synovia showed the
presence of resistin-positive leukocytes (stained reddish-brown) in the lining layer of synovial tissue (left photograph). Incubation of human synovial tissue with irrelevant rabbit
IgG yielded no cell staining (right photograph). Nuclei are counterstainedwith hematoxylin. (B) Evaluation of peripheral blood with ﬂow cytometry revealed the presence of resistin
on the surface of neutrophils (deﬁned as CD16+), T lymphocytes (CD3+), and monocytes (CD14+). (C) Evaluation of synovial ﬂuid of the same RA patient revealed an abundant
expression of resistin on the surface of neutrophils (deﬁned as CD16+) and signiﬁcantly less on T lymphocyte (CD3+) and monocyte (CD14+) cell populations.
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granules.
To conﬁrm that resistin released from human neutrophils upon
fMLF stimulation was of intracellular origin, we studied the asso-
ciation of resistin release and the process of granule mobilization by
measuring the surface upregulation of CR3/CD11b. We found that
release of resistin following stimulation with fMLF (10−7 M) wasFig. 2. Change of surface resistin expression following stimulation of human
neutrophils. A representative histogram shows staining of non-stimulated human
neutrophils incubated with anti-resistin antibodies (open graph, dash line) and the
neutrophils stimulated with fMLF (10−7 M, bold line) or TNFα (103 pg/ml, grey line).
Following stimulation, an increase of resistin expression on the surface of human
neutrophils is visible.associated with an upregulation of CR3/CD11b on the surface of
neutrophils as compared to CR3/CD11b expression on non-stimulated
cells (Fig. 3A). Stimulation of mature neutrophils with TNFα provided
no changes in the surface expression of CR3/CD11b (Fig. 3B). This
indicates that resistin release following fMLF stimulation was a
consequence of granule mobilization. Based on the mobilization
pattern triggered by fMLF on the release of resistin, we hypothesize
that resistin is stored in a subset of easily mobilizable granules, i.e.,
secretory vesicles and/or speciﬁc granules.
3.4. Resistin is enriched in several subcellular fractions in human
neutrophils
To evaluate the intracellular localization of resistin in the neutro-
phil granules, we fractionated neutrophil subcellular granules on a
two-layer percoll gradient (density 1.05 and 1.12). This gradient gave
a separation of azurophil granules (α-fraction), speciﬁc/gelatinase
granules (β-fraction) and plasma membrane/secretory vesicles
(γ-fraction) (Fig. 4A). Granular separation was proven by the analysis
for the speciﬁc granular markers as indicated in M&M. The immuno-
blot analysis of neutrophil fractions visualized resistin as having
molecular weight around 18 kDa in fractions 7, 8 and 9 (Fig. 4B).
According to our granule marker analysis, these fractions are rich in
peroxidase negative granules being property of speciﬁc granules/
gelatinase granules. The anti-resistin antibodies apparently detected a
homodimer form of resistin with a monomer size of 9 kDa. This
Fig. 3. Secretion of resistin induced by stimulation of human neutrophils with fMLF. Human neutrophils (106 cells) were stimulated with increasing concentrations of fMLF (A) or
TNFα (B). Cell-free supernatants were collected by centrifugation and assessed for the presence of resistin and lactoferrin by ELISA. Cell pellets were assessed for CR3/CD11b
expression by ﬂow cytometry. The fMLF-stimulated neutrophils showed that the release of resistin into the supernatants occurs simultaneously with lactoferrin and the increase of
CR3/CD11b expression (indicated by arrow) on the cell membrane. (B) The TNFα stimulated neutrophils showed no signiﬁcant release of lactoferrin into supernatants. No CR3/
CD11b mobilization to the cell membrane was observed.
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resistin was used as a positive control in western blot, although the
recombinant resistin shows also a tetramer form of resistin with
37 kDa size (Fig. 4B, lane 1). In addition, the same anti-resistin anti-Fig. 4. Identiﬁcation of resistin in granules of human neutrophils. (A) Human
neutrophils were fractionated on a two-layer percoll gradient (1.05 and 1.12) and
the individual fractions were subjected for marker analysis, i.e., MPO for azurophil
granules (α-fraction), vitamin B12-binding protein for speciﬁc granules (β-fraction)
and alkaline phosphatase for plasma membrane/secretory vesicles (γ-fraction).
Resistin levels in the fractions of human neutrophils were measured by an ELISA
using alkaline phosphatase dependent substrate and expressed as ng/ml (black bars).
High levels of resistin corresponded to fractions 1–5 (azurophil granules) and to
fractions 8–11 (speciﬁc granules). (B) The immunoblot analysis of neutrophil fractions
under non-reduced conditions indicated localization of resistin in β-fraction (fractions
7, 8, 9 as indicated by arrows). Recombinant resistin was loaded as a positive control as
shown on the ﬁrst lane of the blot (indicated by an arrow).body visualized a band between 10 kDa and 15 kDa in the cytosolic
fractions 18–20 (Fig. 4B).
To further differentiate localization of resistin between speciﬁc
granules and gelatinase granules of human neutrophils, we fraction-
ated disintegrated neutrophils on a three-layer Percoll gradient (as
described in M&M). The immunoblot analysis of fractions 10–18
identiﬁed the homodimer form of resistin (18 kDa size) localized in
fractions 10–13, and associated with vitamin B12-binding protein, a
marker of speciﬁc granules (not shown). Simultaneous immunoblot of
fractions 10–18 with an antibody against gelatinase (a marker protein
present in both speciﬁc and gelatinase granules) indicated the
localization of gelatinase in fractions 14–18. Fractions 10–13 of the
three-layer gradient correspond to the fractions 7–9 of the two-layer
gradient. Thus, localization of resistin was found in β-fraction by both
fractionation procedures and was separated from the fractions
containing gelatinase. Taken together, we show that resistin is indeed
localized to the speciﬁc granules in human neutrophils.
3.5. Quantiﬁcation of resistin in the fractions of human neutrophils
Quantiﬁcation of resistin in the two-layer fractions was done by a
sandwich ELISA (Fig. 4A). Since myeloperoxidase and alkaline
phosphatase are the major components of the α- and γ-fractions,
respectively, their presence could have biased color development in
the assay. To diminish the possible inﬂuence of neutrophil enzymes
on detection of resistin levels in our system, we employed Na-azide,
inhibiting endogenous myeloperoxidase, in all the buffers of ELISA.
Additionally, a speciﬁc resistin–anti-resistin complex formation was
proven by two independent development systems—employing strep-
tavidin conjugated to HRP and to alkaline phosphatase. Both ELISA
systems identiﬁed high levels of resistin in fractions 2–5 as well as in
fractions 8–12 and followed the pattern of protein concentration in
the fractions (Fig. 4A). Only background levels of resistin were de-
tected in fractions 13–23. To further prove the localization of resistin,
fractions 3, 8 and 20 were immunoprecipitated using monoclonal
mouse anti-resistin antibodies (clone 184335) and submitted to mass
spectrometric analysis. A peptide sequence identical to resistin
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ponding to β-granules and α-granules, respectively. These fractions
consisted predominantly of the azurophil and speciﬁc granules.
4. Discussion
In the present study we identiﬁed resistin as a novel protein
mobilized from human neutrophils shortly after stimulation, thus
adding it to the list of potential innate defense mechanisms. Our
ﬁndings suggest neutrophils to be an important source of resistin in
circulation and locally at the site of inﬂammation. It is widely accepted
that neutrophils play a dynamic role in regulation immune responses
through a rapid local release of inﬂammatory mediators from pre-
formed granules during inﬂammation [12–14]. Indeed, components of
azurophil granules show a remarkable accumulation in synovial ﬂuid
of arthritis patients [17]. Local accumulation of resistin at the site of
inﬂammation is reported in synovial ﬂuid during arthritis [6,9,18] and
in saliva of patients with Sjögren's syndrome [8].
In the present study we evaluated subcellular pools of resistin
within the neutrophils. One pool of resistin comprises a membrane-
attached resistin visualized by ﬂow cytometry and being up-regulated
following stimulation of neutrophils with fMLF and TNFα. In
accordance with higher levels of resistin measured in synovial ﬂuid
[6,9], the pool of membrane-attached resistin seems to be bigger on
the leukocytes originating from synovial ﬂuid as compared to
circulating cells. The ability resistin to leave or to be cleaved from
the surface of human neutrophils was not elucidated in our study. The
existence of an insoluble splicing variant of resistin or post-trans-
lationally modiﬁed resistin isoform in membrane fraction of leuko-
cytes has been previously described [19]. Another pool of resistin is
released from neutrophils following stimulation through ligation of
formyl peptide receptors. Based on the results of subcellular fraction
analysis, speciﬁc granules are assigned as the origin of this pool of
resistin. This assumption ﬁnds support in mobilization of CR3/CD11b
as well as lactoferrin, the canonical markers of speciﬁc granules,
simultaneously with resistin. Localization of resistin in speciﬁc
granules was additionally proven by the ELISA and by mass spectro-
metry. Localization of resistin in the speciﬁc granules of neutrophils
suggests its relevance for early appearance at the site of inﬂammation
and emphasizes the role of resistin as a local initiator of cytokine
cascade. It has been shown that human mononuclear cells [20,21] as
well as adipocytes [22] may upon stimulation be local producers of
resistin through de novo protein synthesis.
Immunoblot analysis visualized resistin in the cytosolic fractions of
neutrophils (fractions 19–21). This cytosolic form of resistin was
identiﬁed as a protein with molecular weight 15 kDa being less than a
dimer identiﬁed in the speciﬁc granules of neutrophils (fractions 7–9).
Thus, it may represent an alternative splice variant of resistin, and/or
a different 3D conformational stage of resistin. This cytosolic resistin is
not detected by our ELISA system using a capture-detection pair of
resistin-speciﬁc antibodies. This cytosolic resistin was not detected by
mass spectrometry. Discrepancy of the results obtained in different
visualization methods for resistin may be explained by a selective
speciﬁcity of anti-resistin antibodies used for the immunobot analysis,
alternatively, by a low afﬁnity/recognition with antibodies used for
immunoprecipitation and for ELISA. The suggestion of difference in
afﬁnity/recognition capacity of antibodies in relation to resistin
conformation is supported by the visualization of resistin in α-
fraction by means of ELISA and mass spectrometry.
Recent studies on crystal structure of resistin suggested that
mouse resistin is released from adipocytes and circulates as multimer
corresponding to hexamer and trimer complexes connected by
disulﬁde bonds [3]. Additionally, the proteins of resistin-like family
may form functionally active homo- and heteromeric complexes.
Immunoblot analyses of human neutrophil fractions reveal a dimer as
the major assembly state of secreted resistin. The source of monomersrequired for trimeric complexes is not identiﬁed. Potentially, the
cytosolic compartment with its strong disulﬁde bond reducing po-
tential may serve as one of the sources. The functional role of different
resistin forms as well as membrane-attached resistin is presently
unclear and requires further evaluation.
We have recently shown the key role of resistin as a modulator of
proinﬂammatory cytokine cascade, including IL-6, TNFα, IL-1β, acting
in parallel with TNFα [6]. The observed enrichment with resistin of
the inﬂamed synovial ﬂuid and the presence of resistin on the outer
membrane of leukocytes inside the joint cavity may be equally
important for triggering local inﬂammatory response in RA. At pre-
sent, the knowledge about resistin-induced effects has been mostly
evaluated in monocytes and adipocytes, while information concern-
ing other cell types is limited. Resistin has been shown to function as
chemo attractant for CD4-positive T cells [23]. In contrast, resistin
inhibited chemotaxis and decreased oxidative burst in neutrophils
[24]. Interestingly, resistin-induced effects were mediated through
PI3-kinase activation both in CD4-positive lymphocytes and in
neutrophils. Neutrophils as a potential source of resistin have been
recently attracted attention in the context of bacterial sepsis [25].
Resistin was assigned originating from azurophil granules of
neutrophils.
Localization of resistin in the neutrophils, the ﬁrst cells engaged
in inﬂammation, may provide an important mechanism of recruit-
ment and activation of other immunocompetent cells such as
lymphocytes, monocytes and dendritic cells. Evaluation of modes of
resistin secretion from neutrophils emphasized a new mechanism of
resistin accumulation at the site of inﬂammation supporting the role
of resistin as an important initiator and regulator of inﬂammatory
processes.
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